{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:15:12Z","timestamp":1789852512353,"version":"4.0.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T00:00:00Z","timestamp":1368576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s12253-013-9632-2","type":"journal-article","created":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T23:45:04Z","timestamp":1368488704000},"page":"695-705","source":"Crossref","is-referenced-by-count":14,"title":["Large Cell Lymphoma: Correlation of HIV Status and Prognosis with Differentiation Profiles Assessed by Immunophenotyping"],"prefix":"10.1007","volume":"19","author":[{"given":"Sugeshnee","family":"Pather","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komala","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,15]]},"reference":[{"key":"9632_CR1","first-page":"233","volume-title":"World Health Organisation classification of tumours of haematopoietic and lymphoid tissues","author":"H Stein","year":"2008","unstructured":"Stein H, Warnke RA, Chan WC, Jaffe ES, Chan JKC, Gatter KC, Campo E (2008) Diffuse large B cell lymphoma, not otherwise specified. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Thiele J, Vardiman JW (eds) World Health Organisation classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon, pp 233\u2013237","edition":"4"},{"key":"9632_CR2","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1182\/blood-2004-12-4631","volume":"106","author":"C Hoffmann","year":"2005","unstructured":"Hoffmann C, Tieman M, Schrader C, Janssen D, Wolf E, Vierbuchen M, Parwaresch R, Ernestus K, Plettenberg A, Stoehr A, Fatkenheuer G, Wyen C, Oette M, Horst HA (2005) AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping. Blood 106:1762\u20131769","journal-title":"Blood"},{"key":"9632_CR3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","volume":"28","author":"L Colomo","year":"2004","unstructured":"Colomo L, Loong F, Rives S, Pittaluga S, Mart\u00ednez A, L\u00f3pez-Guillermo A, Ojanguren J, Romagosa V, Jaffe ES, Campo E (2004) Diffuse large B-cell Lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 28:736\u2013747","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"9632_CR4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, M\u00fcller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1):275\u2013282","journal-title":"Blood"},{"key":"9632_CR5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00000478-200404000-00005","volume":"28","author":"CC Chang","year":"2004","unstructured":"Chang CC, McClintock S, Cleveland RP, Trzpuc T, Vesole DH, Logan B, Kajdacsy-Balla A, Perkins SL (2004) Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am J Surg Pathol 28:464\u2013470","journal-title":"Am J Surg Pathol"},{"key":"9632_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6890-9-11","volume":"9","author":"LK Tumwine","year":"2009","unstructured":"Tumwine LK, Agostinelli C, Campidelli C, Othieno E, Wabinga H, Righi S, Falini B, Piccaluga PP, Byarugaba W, Pileri SA (2009) Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda. BMC Clin Pathol 9:1\u20137","journal-title":"BMC Clin Pathol"},{"key":"9632_CR7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2559.2007.02721.x","volume":"51","author":"F Amen","year":"2007","unstructured":"Amen F, Horncastle D, Elderfield K, Banham AH, Bower M, Macdonald D, Kanfer E, Naresh KN (2007) Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients. Histopathology 51:70\u201379","journal-title":"Histopathology"},{"key":"9632_CR8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/path.1924","volume":"208","author":"JJF Muris","year":"2006","unstructured":"Muris JJF, Meijer CJLM, Vos W, van Krieken JH, Jiwa NM, Ossenkoppele GJ, Oudejans JJ (2006) Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma. J Pathol 208:714\u2013723","journal-title":"J Pathol"},{"key":"9632_CR9","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","volume":"15","author":"WW Choi","year":"2009","unstructured":"Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J, Braziel RM, Geng H, Iqbal J, Lenz G, Vose JM, Hans CP, Fu K, Smith LM, Li M, Liu Z, Gascoyne RD, Rosenwald A, Ott G, Rimsza LM, Campo E, Jaffe ES, Jaye DL, Staudt LM, Chan WC (2009) A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 15:5494\u20135502","journal-title":"Clin Cancer Res"},{"key":"9632_CR10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503\u2013511","journal-title":"Nature"},{"key":"9632_CR11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/modpathol.3800493","volume":"19","author":"R Madan","year":"2006","unstructured":"Madan R, Gormley R, Dulau A, Xu D, Walsh D, Ramesh KH, Cannizaro L, Tamas EF, Kumar P, Sparano J, LeValley A, Xue X, Bhattacharyya PK, Ioachim HL, Ratech H (2006) AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles. Mod Pathol 19:438\u2013446","journal-title":"Mod Pathol"},{"issue":"5","key":"9632_CR12","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/0002-9343(78)90537-5","volume":"64","author":"PM Banks","year":"1978","unstructured":"Banks PM, Keller RH, Li C-Y, White WL (1978) Case report malignant lymphoma of plasmablastic identity: a neoplasm with both \u201cimmunoblastic\u201d and plasma cellular features. Am J Med 64(5):906\u2013909","journal-title":"Am J Med"},{"key":"9632_CR13","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","volume":"89","author":"HJ Delecluse","year":"1997","unstructured":"Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U, Huhn D, Schmidt-Westhausen A, Reichart PA, Gross U, Stein H (1997) Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89:1413\u20131420","journal-title":"Blood"},{"key":"9632_CR14","first-page":"256","volume-title":"World Health Organisation classification of tumours of haematopoietic and lymphoid tissues","author":"H Stein","year":"2008","unstructured":"Stein H, Harris NL, Campo E (2008) Plasmablastic lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Thiele J, Vardiman JW (eds) World Health Organisation classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon, pp 256\u2013257","edition":"4"},{"issue":"9","key":"9632_CR15","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1840::AID-CNCR28>3.0.CO;2-C","volume":"86","author":"J Desai","year":"1999","unstructured":"Desai J, Mitnick RJ, Henry DH, Llena J, Sparano JA (1999) Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-Hodgkin lymphoma. Cancer 86(9):1840\u20131847","journal-title":"Cancer"},{"key":"9632_CR16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/00002030-200304110-00011","volume":"17","author":"D Sarker","year":"2003","unstructured":"Sarker D, Thirlwell C, Nelson M, Gazzard B, Bower M (2003) Leptomeningeal disease in AIDS-related non-Hodgkin\u2019s lymphoma. AIDS 17:861\u2013865","journal-title":"AIDS"},{"key":"9632_CR17","unstructured":"Republic of South Africa. Department of Health. National Antiretroviral Treatment Guidelines. Jacana, 2004. Available from http:\/\/southafrica.usembassy.gov\/media\/2004\u2010doh\u2010art\u2010guidelines.pdf"},{"key":"9632_CR18","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/1097-0142(19820815)50:4<690::AID-CNCR2820500412>3.0.CO;2-L","volume":"50","author":"RA Warnke","year":"1982","unstructured":"Warnke RA, Strauchen JA, Burke JS, Hoppe RT, Campbell BA, Dorfman RF (1982) Morphologic types of diffuse large B-cell lymphoma. Cancer 50:690\u2013695","journal-title":"Cancer"},{"key":"9632_CR19","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0959-8049(01)00123-X","volume":"10","author":"RF Ambinder","year":"2001","unstructured":"Ambinder RF (2001) Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Eur J Cancer 10:1209\u20131216","journal-title":"Eur J Cancer"},{"key":"9632_CR20","unstructured":"Nyman H (2010) Prognostic molecular factors and algorithms in diffuse large B-cell lymphoma. [Academic thesis] University of Helsinki"},{"key":"9632_CR21","first-page":"1139","volume-title":"Diagnostic histopathology of tumors vol 2","author":"JKC Chan","year":"2007","unstructured":"Chan JKC (2007) Tumors of the lymphoreticular system\u2014part A: the lymph node. In: Fletcher CDM (ed) Diagnostic histopathology of tumors vol 2, 3rd edn. Churchill-Livingstone Elsevier, London, pp 1139\u20131288","edition":"3"},{"key":"9632_CR22","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00002030-200108170-00005","volume":"15","author":"A Antinori","year":"2001","unstructured":"Antinori A, Cingolani A, Alba L, Ammassari A, Serraino D, Ciancio BC, Palmieri F, De Luca A, Larocca LM, Ruco L, Ippolito G, Cauda R (2001) Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS 15:1483\u20131491","journal-title":"AIDS"},{"key":"9632_CR23","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1365-2141.2001.02656.x","volume":"112","author":"JT Navarro","year":"2001","unstructured":"Navarro JT, Ribera JM, Oriol A (2001) Influence of highly active antiretroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin\u2019s lymphoma treated with CHOP. Br J Haematol 112:909\u2013915","journal-title":"Br J Haematol"},{"key":"9632_CR24","doi-asserted-by":"crossref","unstructured":"Besson C, Goubar A, Gabarre J, Rozenbaum W, Pialoux G, Ch\u00e2telet FP, Katlama C, Charlotte F, Dupont B, Brousse N, Huerre M, Mikol J, Camparo P, Mokhtari K, Tulliez M, Salmon\u2010C\u00e9ron D, Bou\u00e9 F, Costagliola D, Rapha\u00ebl M (2001) Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98:2339\u20132344","DOI":"10.1182\/blood.V98.8.2339"},{"key":"9632_CR25","doi-asserted-by":"crossref","unstructured":"Seaberg EC, Wiley D, Mart\u00ednez\u2010Maza O, Chmiel JS, Kingsley L, Tang Y, Margolick JB, Jacobson LP, Multicenter AIDS Cohort Study (MACS) (2010) Cancer incidence in the multicenter AIDS cohort study before and during the HAART era 1984\u20132007. Cancer 116(23):5507\u20135516","DOI":"10.1002\/cncr.25530"},{"issue":"3","key":"9632_CR26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.bjc.6605756","volume":"103","author":"S Franceschi","year":"2010","unstructured":"Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, Bouchardy C (2010) Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer 103(3):416\u2013422","journal-title":"Br J Cancer"},{"key":"9632_CR27","unstructured":"Republic of South Africa. Department of Health. The South African Antiretroviral Treatment Guidelines 2010. Available from http:\/\/www.uj.ac.za\/EN\/CorporateServices\/ioha\/Documentation\/Documents\/ART%20Guideline.pdf"},{"key":"9632_CR28","unstructured":"van Eeden A. New HIV treatment guidelines: 15 August 2011 [Internet] Available from http:\/\/www.samedical.org\/newsroom\/media-releases\/archived-media-releases\/new-hiv-treatment-guidelines-15-august-2011.html"},{"key":"9632_CR29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00002030-199904160-00018","volume":"13","author":"J Evison","year":"1999","unstructured":"Evison J, Jost J, Ledergerber B, Jost L, Strasser F, Weber R (1999) HIV-associated non-Hodgkin\u2019s lymphoma: highly active antiretroviral therapy improves remission rate of chemotherapy. AIDS 13:732\u2013734","journal-title":"AIDS"},{"key":"9632_CR30","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1696::AID-CNCR25>3.0.CO;2-L","volume":"88","author":"F Thiessard","year":"2000","unstructured":"Thiessard F, Morlat P, Marimoutou C, Labouyrie E, Ragnaud JM, Pellegrin JL, Dupon M, Dabis F, the Groupe d\u2019Epid\u00e9miologie Clinique du SIDA en Aquitaine (GECSA) (2000) Prognostic factors after non-Hodgkin\u2019s lymphoma in patients infected with the human immunodefciency virus: aquitaine cohort, France. Cancer 88:1696\u20131702","journal-title":"Cancer"},{"key":"9632_CR31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00001622-200109000-00003","volume":"13","author":"B Coiffier","year":"2001","unstructured":"Coiffier B (2001) Diffuse large cell lymphoma. Curr Opin Oncol 13:325\u2013334","journal-title":"Curr Opin Oncol"},{"key":"9632_CR32","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","volume":"24","author":"TM Habermann","year":"2006","unstructured":"Habermann TM, Weller EA, Morrison VA et al (2006) Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 24:3121\u20133127","journal-title":"J Clin Oncol"},{"key":"9632_CR33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","volume":"7","author":"M Pfreundschuh","year":"2006","unstructured":"Pfreundschuh M, Trumper L, Osterborg A et al (2006) CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 7:379\u2013391","journal-title":"Lancet Oncol"},{"key":"9632_CR34","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1200\/JCO.2005.09.137","volume":"23","author":"LH Sehn","year":"2005","unstructured":"Sehn LH, Donaldson J, Chhanabhai M et al (2005) Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 23:5027\u20135033","journal-title":"J Clin Oncol"},{"key":"9632_CR35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/348334a0","volume":"348","author":"D Hockenbery","year":"1990","unstructured":"Hockenbery D, Nunez G, Milliman C et al (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334\u2013336","journal-title":"Nature"},{"key":"9632_CR36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.iy.13.040195.002501","volume":"13","author":"S Cory","year":"1995","unstructured":"Cory S (1995) Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 13:513\u2013543","journal-title":"Annu Rev Immunol"},{"key":"9632_CR37","first-page":"9","volume":"34","author":"JC Reed","year":"1997","unstructured":"Reed JC (1997) Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin Hematol 34:9\u201319","journal-title":"Semin Hematol"},{"key":"9632_CR38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/jcp.2009.066597","volume":"62","author":"EC Obermann","year":"2009","unstructured":"Obermann EC, Csato M, Dirnhofer S, Tzankov A (2009) BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma. J Clin Pathol 62:903\u2013907","journal-title":"J Clin Pathol"},{"key":"9632_CR39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood.V87.1.265.265","volume":"87","author":"O Hermine","year":"1996","unstructured":"Hermine O, Haioun C, Lepage E, d\u2019Agay MF, Briere J, Lavignac C, Fillet G, Salles G, Marolleau JP, Diebold J, Reyas F, Gaulard P (1996) Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin\u2019s lymphoma. Blood 87:265\u2013272","journal-title":"Blood"},{"key":"9632_CR40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V90.1.244","volume":"90","author":"R Gascoyne","year":"1997","unstructured":"Gascoyne R, Adomat S, Krajewski S, Krajewska M, Horsman DE, Tolcher AW, O\u2019Reilly SE, Hoskins P, Coldman AJ, Reed JC, Connors JM (1997) Prognostic significance of bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin\u2019s lymphoma. Blood 90:244\u2013251","journal-title":"Blood"},{"key":"9632_CR41","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1182\/blood.V99.4.1136","volume":"99","author":"SL Barrans","year":"2002","unstructured":"Barrans SL, Carter I, Owen RG, Davies FE, Patmore RD, Haynes AP, Morgan GJ, Jack AS (2002) Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood 99:1136\u20131143","journal-title":"Blood"},{"issue":"2","key":"9632_CR42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1365-2559.2001.01196.x","volume":"39","author":"K Ohshima","year":"2001","unstructured":"Ohshima K, Kawasaki C, Muta H, Muta K, Deyev V, Haraoka S, Suzumiya J, Podack ER, Kikuchi M (2001) CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis. Histopathology 39(2):156\u2013162","journal-title":"Histopathology"},{"key":"9632_CR43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0167-5699(92)90199-H","volume":"13","author":"YJ Liu","year":"1992","unstructured":"Liu YJ, Johnson GD, Gordon J, Maclennan IC (1992) Germinal centres in T-cell-dependent antibody responses. Immunol Today 13:17\u201321","journal-title":"Immunol Today"},{"key":"9632_CR44","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/eji.1830270135","volume":"27","author":"G Cutrona","year":"1997","unstructured":"Cutrona G, Dono M, Pastorino S, Ulivi M, Burgio VL, Zupo S, Roncella S, Ferrarini M (1997) The propensity to apoptosis of centrocytes and centroblasts correlates with elevated levels of intracellular myc protein. Eur J Immunol 27:234\u2013238","journal-title":"Eur J Immunol"},{"issue":"9","key":"9632_CR45","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1182\/blood.V94.9.3067","volume":"94","author":"G Cutrona","year":"1999","unstructured":"Cutrona G, Leanza N, Ulivi M, Melioli G, Burgio VL, Mazzarello G, Gabutti G (1999) Expression of CD10 by human T cells that undergo apoptosis both in vitro and in vivo. Blood 94(9):3067\u20133076","journal-title":"Blood"},{"issue":"11","key":"9632_CR46","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/sj.bjc.6600329","volume":"86","author":"G Cutrona","year":"2002","unstructured":"Cutrona G, Tasso P, Dono M, Roncella S, Ulivi M, Carpaneto EM, Fontana V, Comis M, Morabito F, Spinelli M, Frascella E, Boffa LC, Basso G, Pistoia, Ferrarini M (2002) CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL. Br J Cancer 86(11):1776\u20131785","journal-title":"Br J Cancer"},{"key":"9632_CR47","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood.V98.4.945","volume":"98","author":"IS Lossos","year":"2001","unstructured":"Lossos IS, Jones CD, Warnke R, Natkunam Y, Kaizer H, Zehnder JL, Tibshirani R, Levy R (2001) Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood 98:945\u2013951","journal-title":"Blood"},{"key":"9632_CR48","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1182\/blood-2005-10-4222","volume":"107","author":"JN Winter","year":"2006","unstructured":"Winter JN, Weller EA, Horning SJ, Krajewska M, Variakojis D, Habermann TM, Fisher RI, Kurtin PJ, Macon WR, Chhanabhai M, Felgar RE, Hsi ED, Medeiros LJ, Weick JK, Reed JC, Gascoyne RD (2006) Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study. Blood 107:4207\u20134213","journal-title":"Blood"},{"key":"9632_CR49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.soncn.2006.01.004","volume":"22","author":"AM Levine","year":"2006","unstructured":"Levine AM (2006) AIDS-related lymphoma. Semin Oncol Nurs 22:80\u201389","journal-title":"Semin Oncol Nurs"},{"key":"9632_CR50","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ajh.21250","volume":"83","author":"J Castillo","year":"2008","unstructured":"Castillo J, Pantanowithz L, Dezube BJ (2008) HIV-associated plasmablastic lymphoma: a literature review of 112 cases. Am J Hematol 83:804\u2013809","journal-title":"Am J Hematol"},{"key":"9632_CR51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1368-8375(01)00018-5","volume":"38","author":"CM Flaitz","year":"2002","unstructured":"Flaitz CM, Nichols, Walling DM, Hicks MJ (2002) Case report. Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations. Oral Oncol 38:96\u2013102","journal-title":"Oral Oncol"},{"key":"9632_CR52","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/jcp.2009.064758","volume":"62","author":"P Chabay","year":"2009","unstructured":"Chabay P, De Matteo E, Lorenzetti M, Gutierrez M, Narbaitz M, Aversa L, Preciado MV (2009) Case report: vulvar plasmablastic lymphoma in a HIV-positive child: a novel extraoral localisation. J Clin Pathol 62:644\u2013646","journal-title":"J Clin Pathol"},{"key":"9632_CR53","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.tripleo.2005.03.028","volume":"100","author":"R Radhakrishnan","year":"2005","unstructured":"Radhakrishnan R, Suhas S, Kumar RV, Krishnanand G, Srinivasan R, Rao NN (2005) Plasmablastic lymphoma of the oral cavity in an HIV-positive child. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100:725\u2013731","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"9632_CR54","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/pbc.22547","volume":"55","author":"A Gogia","year":"2010","unstructured":"Gogia A, Bakhshi S (2010) Letter to the editor. Plasmablastic lymphoma of oral cavity in an HIV negative child. Pediatr Blood Cancer 55:390\u2013391","journal-title":"Pediatr Blood Cancer"},{"key":"9632_CR55","unstructured":"Pather S, MacKinnon D, Padayachee RS (2012) Plasmablastic lymphoma in paediatric patients: Clinicopathologic study of three cases. Ann Diagn Pathol. Accepted for publication Aug 2012"},{"key":"9632_CR56","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tripleo.2004.11.050","volume":"100","author":"MA Scheper","year":"2005","unstructured":"Scheper MA, Nikitakis NG, Fernandes R, Gocke CD, Ord RA, Sauk JJ (2005) Oral plasmablastic lymphoma in an HIV-negative patient: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100:198\u2013206","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"9632_CR57","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5858\/2004-128-581-PLOTCL","volume":"128","author":"F Lin","year":"2004","unstructured":"Lin F, Zhang K, Quiery AT, Prichard J, Schuerch C (2004) Plasmablastic Lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient. A case report and review of the literature. Arch Pathol Lab Med 128:581\u2013584","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"9632_CR58","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.anndiagpath.2010.05.011","volume":"15","author":"B Guan","year":"2011","unstructured":"Guan B, Zhang X, Hu W, Rao Q, Wang Y, Zhu Y, Wang H, Ma H, Zhou H, Zhou X (2011) Plasmablastic lymphoma of the oral cavity in an HIV-negative patient. Ann Diagn Pathol 15(6):436\u2013440","journal-title":"Ann Diagn Pathol"},{"key":"9632_CR59","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2559.2003.01636.x","volume":"42","author":"R Chetty","year":"2003","unstructured":"Chetty R, Hlatswayo N, Muc R, Sabaratnam R, Gatter K (2003) Plasmablastic lymphoma in HIV\u2009+\u2009patients: an expanding spectrum. Histopathology 42:605\u2013609","journal-title":"Histopathology"},{"key":"9632_CR60","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/01.pas.0000173023.02724.1f","volume":"29","author":"HY Dong","year":"2005","unstructured":"Dong HY, Scadden DT, de Leval L, Tang Z, Isaacson PG, Harris NL (2005) Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus\u2013associated extramedullary plasmacytic neoplasm. Am J Surg Pathol 29:1633\u20131641","journal-title":"Am J Surg Pathol"},{"key":"9632_CR61","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1073\/pnas.90.1.352","volume":"90","author":"R Rochford","year":"1993","unstructured":"Rochford R, Hobbs MV, Garnier JL, Cooper NR, Cannon MJ (1993) Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes. Proc Natl Acad Sci U S A 90:352\u2013356","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9632-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-013-9632-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9632-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T23:05:28Z","timestamp":1645052728000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-013-9632-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,15]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["9632"],"URL":"https:\/\/doi.org\/10.1007\/s12253-013-9632-2","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,15]]}}}